Dialysis clinic operator DaVita (DVA +3.1%) signs a new, seven-year agreement to receive Amgen's...

|About: DaVita HealthCare Partners ... (DVA)|By:, SA News Editor

Dialysis clinic operator DaVita (DVA +3.1%) signs a new, seven-year agreement to receive Amgen's (AMGN -0.5%) anti-anemia drug Epogen. In an SEC filing, Amgen discloses that the Epogen it supplies will meet at least 90% of DaVita's requirements for erythropoiesis stimulating agents in clinics in the U.S. and Puerto Rico.